Madison, WI, United States of America

Andrew M Gulick


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrew M. Gulick

Introduction

Andrew M. Gulick is an accomplished inventor based in Madison, Wisconsin, known for his significant contribution to the field of enzymology. With a focus on enhancing the functionality of glutathione S-transferase isoforms, his work holds promise for advancements in cancer therapeutics. His innovative approach has garnered attention and recognition in the research community.

Latest Patents

Gulick holds a notable patent titled "Glutathione S-transferase isoforms." This patent describes a method for creating novel isoforms of the enzyme glutathione S-transferase with enhanced activity against specific toxic agents in host cells. The process involves site-directed mutagenesis and selection with the targeted agent, highlighting the enzyme's electrophile binding site, which can be modified without compromising its enzymatic activity. His techniques for improving the expression, activity, or localization of the enzyme in mammalian cells could potentially lead to better cancer treatment options by providing certain cell groups with heightened resistance to antineoplastic agents.

Career Highlights

Gulick's contributions to science and innovation are underscored by his association with the Wisconsin Alumni Research Foundation. His work there emphasizes the integration of academic research and practical applications, facilitating advancements in enzymatic biochemistry.

Collaborations

Throughout his career, Andrew has collaborated with esteemed colleagues, including William E. Fahl and T. Herbert Manoharan. This teamwork has further enriched his research endeavors, leading to innovative discoveries and solutions in the field.

Conclusion

In summary, Andrew M. Gulick exemplifies the spirit of innovation through his patent on glutathione S-transferase isoforms. His work holds significant implications for cancer therapeutics and showcases how collaborative efforts can drive advancements in scientific research. As he continues to contribute to the field, Gulick's inventions are set to make a lasting impact on the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…